Possible molecular mechanisms to account for the involvement of tryptase in the pathogenesis of psoriasis

References

• Schubert C, Christophers E. Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 1985; 277: 352–358
   PubMed Web of Science ®Google Scholar
• Petersen JL, Hansen U, Kristensen JK, Nietsen H, Skor PS, Nielsen HJ. Studies on mast cells and histamine release in psoriasis: The effect of ranitidine. Acta Derm Venereol 1998; 78: 190–193
   PubMed Web of Science ®Google Scholar
• Michalesson G, Hagforsen E, Pihl-Lundin I. The number of mast cells is highly increased in noninvolved skin in psoriasis. Acta Derm Venereol 1995; 75: 169
   PubMedGoogle Scholar
• Pestielli E, Caproni M, Barbara G, et al. Cetirizine reduces in a double blind controlled study the number of tryptase positive mast cells of psoriatic patients. Int J Tissue React 2001; 23(3)97–103
   PubMedGoogle Scholar
• Caughey GH. New developments in the genetics and activation of mast cell proteases. Mol Immunol 2001; 38: 1353–1357
   Google Scholar
• Fajardo I, Pejler G. Human mast cell tryptase is a gelatinase. J Immunol 2003; 171: 1493–1499
   PubMedGoogle Scholar
• He S, Peng Q, Walls AF. Potent induction of a neutrophil and eosinophil-rich infiltrate in vivo by human mast cell tryptase: Selective enhancement of eosinophil recruitment by histamine. J Immunol 1997; 159: 6216–6225
   PubMed Web of Science ®Google Scholar
• Compten SJ, Carins JA, Holgate ST, Walls AF. The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 1998; 161: 1939–1946
   PubMedGoogle Scholar
• Toruniowa B, Jablonska S. Mast-cells in the initial stages of psoriasis. Arch Dermatol Res 1988; 280: 189–193
   PubMedGoogle Scholar
• Harvima IT, Naukkarinen A, Paukkonen K, Harvima RJ, Aalto ML, Schwartz LB, Horsmanhemio M. Mast-cell tryptase and chymase in developing and mature psoriatic lesions. Arch Dermatol Res 1993; 285: 184–192
   PubMedGoogle Scholar
• Carins JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells. J Immunol 1996; 156: 275–283
   PubMedGoogle Scholar
• Naukkarinen A, Harvima IT, Alto ML, Horsmanheimo M. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Int J Dermatol 1994; 33: 361–366
   PubMedGoogle Scholar
• Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF. Generation of C3a anaphylotoxin from human C3 by human mast cell tryptase. J Immunol 1983; 130: 1891–1985
   PubMed Web of Science ®Google Scholar
• He S, Walls AF. Human mast cell tryptase: A stimulus of microvascular leakage and mast cell activation. Eur J Pharmacol 1997; 328: 89–97
   PubMed Web of Science ®Google Scholar
• Christophers E, Mrowietz U. Psoriasis. Fitzpatrick's dermatology in general medicine, IM Treedberg, AZ Eisen, K Wolff, KF Austen, LA Goldsmith, SI Katz, TB Fitzpatrick. McGraw-Hill, New York 1999; Vol. 1: 495–521
   Google Scholar
• Linder JR, Kahn ML, Coughlin SR, et al. Delayed onset of inflammation in protease activated receptor-2-deficient mice. J Immunol 2000; 165: 6504–6510
   PubMedGoogle Scholar
• Walls AF, He S, Teran LM, Buckley MG, Jung K, Holgate ST, Shute JK, Carins JA. Granulocyte recruitment by human mast cell trypatse. Int Arch Allergy Appl Immunol 1995; 107(1–3)372–373
   Google Scholar
• Walls AF, Bennet AR, Suerias-Diaz J, Olsson H. The kininogenase activity of human mast cell tryptase. Biochem Soc Trans 1992; 20: 2605
   Google Scholar
• Poblete MT, Reynolds NJ, Figueroa CD, Burton JL, Muller-Estrel W, Bhoola KD. Tissue kallikrein and kininogen in human sweat glands and psoriatic skin. Br J Dermatol 1991; 124: 236–241
   PubMedGoogle Scholar
• Vergnolle N. Proteinase-activating receptor-2 activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 1999; 163: 5064–5069
   PubMedGoogle Scholar
• Ruoss SJ, Hartmann T, Caughey GH. Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Investig 1991; 88: 493–499
   PubMed Web of Science ®Google Scholar
• Miura H, Sano S, Higashiyama M, Yoshikawa K, Itami S. Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: Dermal fibroblasts play a regulatory role in developing psoriatic lesions. Arch Dermatol Res 2000; 292(12)590–597
   PubMedGoogle Scholar
• Mizutani H, Ohmoto Y, Mizutani T, Murata M, Shimizu M. Role of increased production of monocytes TNF-α, IL-1β, and IL-6 in psoriasis: Relation to focal infection, disease activity, and response to treatment. J Dermatol Sci 1997; 14: 145–153
   PubMed Web of Science ®Google Scholar
• Malamud V, Vaaknin A, Abramsky O, Mor M, Burgess LE, Ben-Yehudah A, Lorberboum-Galski H. Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF-alpha, IL-6, and IL-1 beta: Possible relevance to multiple sclerosis. J Neuroimmunol 2003; 138(1–2)115–122
   PubMedGoogle Scholar
• Fields RC, Schoenecker JG, Hart JP, Hoffman MR, Pizzo SV, Lawson JH. Protease-activated recetor-2 signaling triggers dendritic cell development. Am J Pathol 2003; 162: 1817–1822
   PubMed Web of Science ®Google Scholar
• Lees M, Taylor DJ, Wolley DE. Mast cell proteinase activates precursor forms of collegenase and stromelysin, but not of gelatinase A and B. Eur J Biochem 1994; 223(1)171–177
   PubMedGoogle Scholar
• Suomela S, Kariniemi AL, Snellman E, Saarialho-Kere U. Metalloelastae (MMP-12) and 9α-KDa gelatinase (MMP-9) as well as their inhibitors, TIMP-1 and -3, are expressed in psoriatic lesions. Exp Dermatol 2001; 10: 175–183
   PubMed Web of Science ®Google Scholar
• Lavery JP, Lisse JR. Preliminary study of the tryptase levels in the synovial fluid of patients with inflammatory arthritis. Ann Allergy 1994; 72: 425–427
   PubMedGoogle Scholar
• Gruber BL, Marchese MJ, Suzuki K, Schwartz LB, Ckada Y, Nagase H, Ramamurthy NS. Synovial procollagenase activation by human mast cells tryptase: Dependence upon matrix metalloproteinase 3 activation. J Clin Investig 1989; 84: 1657–1662
   PubMed Web of Science ®Google Scholar